Biotech Execs Speak Out Against Trump’s Immigration Ban; Big Pharma Remains Mostly Silent

Letter initiated by six CEOs drew 'absolutely overwhelming' response as 163 leaders of primarily small biotech and venture capital firms signed on; tech firms join court fight.